Attention Deficit Hyperactivity Disorder(ADHD) Market Industry Analysis Report By Drug Type, Demographic, Distribution C

1. Global ADHD drugs market size is forecast to grow by USD 5.29 billion during 2019-2023, at a CAGR of 6% with stimulants segment having the largest market share. Attention Deficit Hyperactivity Disorder Drugs market analysis indicates growth will be driven by rising government support. The reformulation of marketed drugs will also impact ADHD medication industry worth. With the growing prevalence of attention deficit hyperactivity disorder across the world, the ADHD market is witnessing an increase in the number of government initiatives to promote the awareness of the disease and to fund drug development in the area mental health therapeutics. For instance, in 2016, the US Department of Health and Human Services (HHS) donated USD 3,454 million to the Substance Abuse and Mental Health Services Administration (SAMHSA) to address the needs of people with mental illnesses. Such rising government support to help people with ADHD will drive market growth during the forecast period. Looking for more information on this market?Request a free sample report http://bit.ly/33Y4jSE As per Technavio, the reformulation of marketed drugs will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global attention deficit hyperactivity disorder (ADHD) drugs market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023. Global attention deficit hyperactivity disorder (ADHD) drugs market: Reformulation of Marketed Drugs Earlier, the ADHD market was dominated by immediate-release tablets for oral use. However, the short duration of action of these drugs necessitates multiple dosing, thereby decreasing patient compliance. Thus, to combat this situation, vendors in the market are increasingly focusing on the reformulation of various marketed drugs. The reformulation of marketed drugs provides an opportunity to grab patent term extensions, which can delay the entry of generic versions in the market. The reformulation of drugs also helps in reducing the dosage frequency, thereby increasing patient compliance. Global attention deficit hyperactivity disorder (ADHD) drugs market: Segmentation analysis

2. This market research report segments the global attention deficit hyperactivity disorder (ADHD) drugs market by product (stimulants, and non-stimulants) and geographic regions (North America, Europe, Asia, and ROW) The North American region led the market in 2018, followed by Europe, Asia, and ROW, respectively. The growth of the ADHD medications market in North America can be attributed to the rising prevalence of ADHD among the population in the US and the increased availability of approved medication therapy for the treatment. Some of the key topics covered in the report include: Market Landscape Market ecosystem Market characteristics Market segmentation analysis Market Sizing • • • Market definition Market size and forecast Five Forces Analysis • • Market Segmentation Geographical Segmentation Regional comparison Key leading countries Market Drivers • • Market Challenges Market Trends Vendor Landscape Vendors covered Vendor classification Market positioning of vendors Competitive scenario • • • •